Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Advances in Enzyme Regulation|January 1, 1992
Effect of Ha-ras on mitogen-induced Ca(2+)- and K(+)-fluxesH Grunicke, K Maly, M Meyer, et al.
Advances in Enzyme Regulation|January 1, 1985
Plasma membrane as target of alkylating agentsH Grunicke, W Doppler, J Hofmann, et al.
The Journal of Biological Chemistry|September 12, 2001
Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-RasS Kampfer, M Windegger, F Hochholdinger, et al.
Molecular and Cellular Biology|April 1, 1996
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytesG Baier-Bitterlich, F Uberall, B Bauer, et al.
FEBS Letters|June 18, 2002
Critical role of protein kinase C alpha and calcium in growth factor induced activation of the Na(+)/H(+) exchanger NHE1Karl Maly, Kukka Strese, Sonja Kampfer, et al.
British Journal of Cancer|January 1, 1997
Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440)J Hofmann, I Utz, M Spitaler, et al.
Cancer Research|January 19, 1999
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell linesT Putz, Z Culig, I E Eder, et al.
The Biochemical Journal|September 21, 2001
Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iotaJ Mwanjewe, M Spitaler, M Ebner, et al.
British Journal of Cancer|May 18, 2001
MDR1 causes resistance to the antitumour drug miltefosineM Rybczynska, R Liu, P Lu, et al.
British Journal of Cancer|September 1, 1996
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistanceV Gekeler, R Boer, F Uberall, et al.
Pageof 9